nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CHRM1—schizophrenia	0.148	0.191	CbGaD
Maprotiline—HTR7—schizophrenia	0.12	0.155	CbGaD
Maprotiline—SLC6A3—schizophrenia	0.105	0.136	CbGaD
Maprotiline—HTR2C—schizophrenia	0.0947	0.123	CbGaD
Maprotiline—DRD2—schizophrenia	0.078	0.101	CbGaD
Maprotiline—CYP1A2—schizophrenia	0.0714	0.0926	CbGaD
Maprotiline—HTR2A—schizophrenia	0.0603	0.0781	CbGaD
Maprotiline—CYP2D6—schizophrenia	0.0551	0.0715	CbGaD
Maprotiline—ABCB1—schizophrenia	0.0394	0.051	CbGaD
Maprotiline—SLC6A2—locus ceruleus—schizophrenia	0.00469	0.0582	CbGeAlD
Maprotiline—HTR7—locus ceruleus—schizophrenia	0.00452	0.0561	CbGeAlD
Maprotiline—HTR2A—locus ceruleus—schizophrenia	0.00282	0.035	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—schizophrenia	0.00276	0.0342	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—schizophrenia	0.00267	0.0331	CbGeAlD
Maprotiline—HTR7—pons—schizophrenia	0.00261	0.0323	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—schizophrenia	0.00249	0.0309	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—schizophrenia	0.0024	0.0298	CbGeAlD
Maprotiline—HTR2A—cerebellar cortex—schizophrenia	0.0023	0.0285	CbGeAlD
Maprotiline—HTR7—telencephalic ventricle—schizophrenia	0.00214	0.0266	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—schizophrenia	0.00203	0.0252	CbGeAlD
Maprotiline—HTR2A—pons—schizophrenia	0.00163	0.0202	CbGeAlD
Maprotiline—CYP1A2—urine—schizophrenia	0.00156	0.0194	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—schizophrenia	0.0015	0.0186	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—schizophrenia	0.00134	0.0166	CbGeAlD
Maprotiline—HTR2A—urine—schizophrenia	0.00122	0.0152	CbGeAlD
Maprotiline—HTR2A—pineal body—schizophrenia	0.00116	0.0144	CbGeAlD
Maprotiline—CYP2D6—urine—schizophrenia	0.00111	0.0138	CbGeAlD
Maprotiline—HTR7—blood plasma—schizophrenia	0.00102	0.0127	CbGeAlD
Maprotiline—CYP1A2—blood plasma—schizophrenia	0.000815	0.0101	CbGeAlD
Maprotiline—CHRM4—nervous system—schizophrenia	0.000731	0.00907	CbGeAlD
Maprotiline—CHRM2—forebrain—schizophrenia	0.000722	0.00896	CbGeAlD
Maprotiline—SLC6A3—forebrain—schizophrenia	0.00072	0.00894	CbGeAlD
Maprotiline—CHRM4—central nervous system—schizophrenia	0.000704	0.00873	CbGeAlD
Maprotiline—HTR2C—forebrain—schizophrenia	0.000696	0.00864	CbGeAlD
Maprotiline—CHRM2—telencephalon—schizophrenia	0.000664	0.00824	CbGeAlD
Maprotiline—SLC6A3—telencephalon—schizophrenia	0.000662	0.00822	CbGeAlD
Maprotiline—CHRM1—forebrain—schizophrenia	0.000657	0.00816	CbGeAlD
Maprotiline—HTR2C—telencephalon—schizophrenia	0.00064	0.00795	CbGeAlD
Maprotiline—HTR2A—blood plasma—schizophrenia	0.000637	0.00791	CbGeAlD
Maprotiline—CHRM1—telencephalon—schizophrenia	0.000605	0.0075	CbGeAlD
Maprotiline—CHRM3—forebrain—schizophrenia	0.000588	0.0073	CbGeAlD
Maprotiline—SLC6A2—forebrain—schizophrenia	0.000581	0.00721	CbGeAlD
Maprotiline—CYP2D6—blood plasma—schizophrenia	0.000581	0.00721	CbGeAlD
Maprotiline—Sertraline—MAOA—schizophrenia	0.00058	0.0886	CrCbGaD
Maprotiline—CHRM5—nervous system—schizophrenia	0.000571	0.00709	CbGeAlD
Maprotiline—HTR7—forebrain—schizophrenia	0.00056	0.00695	CbGeAlD
Maprotiline—CHRM4—brain—schizophrenia	0.000559	0.00693	CbGeAlD
Maprotiline—CHRM5—central nervous system—schizophrenia	0.00055	0.00683	CbGeAlD
Maprotiline—CHRM3—telencephalon—schizophrenia	0.000541	0.00671	CbGeAlD
Maprotiline—SLC6A2—telencephalon—schizophrenia	0.000534	0.00663	CbGeAlD
Maprotiline—DRD2—forebrain—schizophrenia	0.000529	0.00657	CbGeAlD
Maprotiline—ORM1—blood—schizophrenia	0.000518	0.00643	CbGeAlD
Maprotiline—HTR7—telencephalon—schizophrenia	0.000515	0.00639	CbGeAlD
Maprotiline—Sertraline—SLC6A3—schizophrenia	0.0005	0.0764	CrCbGaD
Maprotiline—DRD2—telencephalon—schizophrenia	0.000487	0.00604	CbGeAlD
Maprotiline—SLC6A3—midbrain—schizophrenia	0.000476	0.0059	CbGeAlD
Maprotiline—HTR2C—midbrain—schizophrenia	0.00046	0.00571	CbGeAlD
Maprotiline—ORM1—endocrine gland—schizophrenia	0.000449	0.00558	CbGeAlD
Maprotiline—SLC6A2—gonad—schizophrenia	0.000446	0.00553	CbGeAlD
Maprotiline—CHRM5—brain—schizophrenia	0.000437	0.00542	CbGeAlD
Maprotiline—HTR7—gonad—schizophrenia	0.00043	0.00533	CbGeAlD
Maprotiline—ORM1—nervous system—schizophrenia	0.00042	0.00522	CbGeAlD
Maprotiline—CHRM2—endocrine gland—schizophrenia	0.000419	0.0052	CbGeAlD
Maprotiline—HRH1—forebrain—schizophrenia	0.000418	0.00519	CbGeAlD
Maprotiline—ABCB1—blood plasma—schizophrenia	0.000418	0.00518	CbGeAlD
Maprotiline—ORM1—central nervous system—schizophrenia	0.000405	0.00502	CbGeAlD
Maprotiline—CHRM2—nervous system—schizophrenia	0.000392	0.00487	CbGeAlD
Maprotiline—SLC6A3—nervous system—schizophrenia	0.000391	0.00485	CbGeAlD
Maprotiline—HRH1—telencephalon—schizophrenia	0.000384	0.00477	CbGeAlD
Maprotiline—CHRM1—endocrine gland—schizophrenia	0.000381	0.00473	CbGeAlD
Maprotiline—HTR2C—nervous system—schizophrenia	0.000378	0.00469	CbGeAlD
Maprotiline—CHRM2—central nervous system—schizophrenia	0.000377	0.00469	CbGeAlD
Maprotiline—SLC6A3—central nervous system—schizophrenia	0.000376	0.00467	CbGeAlD
Maprotiline—HTR7—blood—schizophrenia	0.000374	0.00465	CbGeAlD
Maprotiline—Sertraline—SLC6A4—schizophrenia	0.000374	0.0571	CrCbGaD
Maprotiline—HTR7—midbrain—schizophrenia	0.00037	0.00459	CbGeAlD
Maprotiline—SLC6A3—cerebellum—schizophrenia	0.000368	0.00457	CbGeAlD
Maprotiline—HTR2C—central nervous system—schizophrenia	0.000364	0.00452	CbGeAlD
Maprotiline—CHRM1—nervous system—schizophrenia	0.000357	0.00443	CbGeAlD
Maprotiline—DRD2—midbrain—schizophrenia	0.00035	0.00434	CbGeAlD
Maprotiline—HTR2A—forebrain—schizophrenia	0.000349	0.00433	CbGeAlD
Maprotiline—CHRM1—central nervous system—schizophrenia	0.000344	0.00426	CbGeAlD
Maprotiline—CHRM3—endocrine gland—schizophrenia	0.000341	0.00424	CbGeAlD
Maprotiline—Sertraline—CYP1A2—schizophrenia	0.00034	0.052	CrCbGaD
Maprotiline—SLC6A2—endocrine gland—schizophrenia	0.000337	0.00418	CbGeAlD
Maprotiline—HTR7—endocrine gland—schizophrenia	0.000325	0.00403	CbGeAlD
Maprotiline—HTR2A—telencephalon—schizophrenia	0.000321	0.00399	CbGeAlD
Maprotiline—CHRM3—nervous system—schizophrenia	0.000319	0.00396	CbGeAlD
Maprotiline—CYP2D6—forebrain—schizophrenia	0.000318	0.00395	CbGeAlD
Maprotiline—SLC6A2—nervous system—schizophrenia	0.000315	0.00391	CbGeAlD
Maprotiline—CHRM3—central nervous system—schizophrenia	0.000307	0.00382	CbGeAlD
Maprotiline—DRD2—endocrine gland—schizophrenia	0.000307	0.00381	CbGeAlD
Maprotiline—HTR7—nervous system—schizophrenia	0.000304	0.00377	CbGeAlD
Maprotiline—SLC6A2—central nervous system—schizophrenia	0.000304	0.00377	CbGeAlD
Maprotiline—Metixene—CHRM1—schizophrenia	0.000301	0.0461	CrCbGaD
Maprotiline—CHRM2—brain—schizophrenia	0.0003	0.00372	CbGeAlD
Maprotiline—SLC6A3—brain—schizophrenia	0.000299	0.00371	CbGeAlD
Maprotiline—CYP1A2—blood—schizophrenia	0.000299	0.00371	CbGeAlD
Maprotiline—HTR7—central nervous system—schizophrenia	0.000293	0.00363	CbGeAlD
Maprotiline—CYP2D6—telencephalon—schizophrenia	0.000293	0.00363	CbGeAlD
Maprotiline—HTR2C—brain—schizophrenia	0.000289	0.00359	CbGeAlD
Maprotiline—DRD2—nervous system—schizophrenia	0.000287	0.00357	CbGeAlD
Maprotiline—HTR7—cerebellum—schizophrenia	0.000286	0.00355	CbGeAlD
Maprotiline—DRD2—central nervous system—schizophrenia	0.000277	0.00343	CbGeAlD
Maprotiline—CHRM1—brain—schizophrenia	0.000273	0.00339	CbGeAlD
Maprotiline—DRD2—cerebellum—schizophrenia	0.00027	0.00336	CbGeAlD
Maprotiline—HTR2A—gonad—schizophrenia	0.000268	0.00333	CbGeAlD
Maprotiline—Sertraline—CYP2D6—schizophrenia	0.000263	0.0401	CrCbGaD
Maprotiline—CYP1A2—endocrine gland—schizophrenia	0.000259	0.00322	CbGeAlD
Maprotiline—Atomoxetine—HTR6—schizophrenia	0.000246	0.0376	CrCbGaD
Maprotiline—CHRM3—brain—schizophrenia	0.000244	0.00303	CbGeAlD
Maprotiline—HRH1—endocrine gland—schizophrenia	0.000243	0.00301	CbGeAlD
Maprotiline—SLC6A2—brain—schizophrenia	0.000241	0.00299	CbGeAlD
Maprotiline—HTR2A—blood—schizophrenia	0.000234	0.0029	CbGeAlD
Maprotiline—HTR7—brain—schizophrenia	0.000232	0.00288	CbGeAlD
Maprotiline—HTR2A—midbrain—schizophrenia	0.000231	0.00286	CbGeAlD
Maprotiline—ABCB1—forebrain—schizophrenia	0.000229	0.00284	CbGeAlD
Maprotiline—HRH1—nervous system—schizophrenia	0.000227	0.00282	CbGeAlD
Maprotiline—DRD2—brain—schizophrenia	0.00022	0.00273	CbGeAlD
Maprotiline—HRH1—central nervous system—schizophrenia	0.000219	0.00271	CbGeAlD
Maprotiline—Nortriptyline—HTR6—schizophrenia	0.000215	0.0328	CrCbGaD
Maprotiline—Protriptyline—SLC6A4—schizophrenia	0.000215	0.0328	CrCbGaD
Maprotiline—CYP2D6—blood—schizophrenia	0.000213	0.00264	CbGeAlD
Maprotiline—ABCB1—telencephalon—schizophrenia	0.00021	0.00261	CbGeAlD
Maprotiline—HTR2A—endocrine gland—schizophrenia	0.000203	0.00251	CbGeAlD
Maprotiline—Metixene—HTR2C—schizophrenia	0.000193	0.0295	CrCbGaD
Maprotiline—HTR2A—nervous system—schizophrenia	0.00019	0.00235	CbGeAlD
Maprotiline—Sertraline—ABCB1—schizophrenia	0.000188	0.0287	CrCbGaD
Maprotiline—CYP2D6—endocrine gland—schizophrenia	0.000185	0.00229	CbGeAlD
Maprotiline—HTR2A—central nervous system—schizophrenia	0.000183	0.00227	CbGeAlD
Maprotiline—HTR2A—cerebellum—schizophrenia	0.000178	0.00221	CbGeAlD
Maprotiline—ABCB1—gonad—schizophrenia	0.000176	0.00218	CbGeAlD
Maprotiline—HRH1—brain—schizophrenia	0.000173	0.00215	CbGeAlD
Maprotiline—CYP2D6—nervous system—schizophrenia	0.000173	0.00214	CbGeAlD
Maprotiline—CYP2D6—central nervous system—schizophrenia	0.000166	0.00206	CbGeAlD
Maprotiline—CYP2D6—cerebellum—schizophrenia	0.000163	0.00202	CbGeAlD
Maprotiline—Nortriptyline—CHRM1—schizophrenia	0.000155	0.0236	CrCbGaD
Maprotiline—ABCB1—blood—schizophrenia	0.000153	0.0019	CbGeAlD
Maprotiline—ABCB1—midbrain—schizophrenia	0.000151	0.00188	CbGeAlD
Maprotiline—Protriptyline—CYP2D6—schizophrenia	0.000151	0.0231	CrCbGaD
Maprotiline—Imipramine—HTR6—schizophrenia	0.00015	0.0229	CrCbGaD
Maprotiline—HTR2A—brain—schizophrenia	0.000145	0.0018	CbGeAlD
Maprotiline—Atomoxetine—HTR1B—schizophrenia	0.000139	0.0213	CrCbGaD
Maprotiline—ABCB1—endocrine gland—schizophrenia	0.000133	0.00165	CbGeAlD
Maprotiline—CYP2D6—brain—schizophrenia	0.000132	0.00164	CbGeAlD
Maprotiline—Desipramine—CHRM1—schizophrenia	0.000127	0.0195	CrCbGaD
Maprotiline—Atomoxetine—SLC6A3—schizophrenia	0.000126	0.0192	CrCbGaD
Maprotiline—ABCB1—nervous system—schizophrenia	0.000124	0.00154	CbGeAlD
Maprotiline—ABCB1—central nervous system—schizophrenia	0.00012	0.00148	CbGeAlD
Maprotiline—ABCB1—cerebellum—schizophrenia	0.000117	0.00145	CbGeAlD
Maprotiline—Atomoxetine—HTR2C—schizophrenia	0.000114	0.0174	CrCbGaD
Maprotiline—Imipramine—CHRM1—schizophrenia	0.000108	0.0165	CrCbGaD
Maprotiline—Protriptyline—ABCB1—schizophrenia	0.000108	0.0165	CrCbGaD
Maprotiline—Nortriptyline—HTR2C—schizophrenia	9.93e-05	0.0152	CrCbGaD
Maprotiline—Nortriptyline—HTR1A—schizophrenia	9.64e-05	0.0147	CrCbGaD
Maprotiline—ABCB1—brain—schizophrenia	9.5e-05	0.00118	CbGeAlD
Maprotiline—Atomoxetine—SLC6A4—schizophrenia	9.42e-05	0.0144	CrCbGaD
Maprotiline—Desipramine—SLC6A3—schizophrenia	9.06e-05	0.0138	CrCbGaD
Maprotiline—Imipramine—HTR7—schizophrenia	8.78e-05	0.0134	CrCbGaD
Maprotiline—Nortriptyline—SLC6A4—schizophrenia	8.23e-05	0.0126	CrCbGaD
Maprotiline—Nortriptyline—DRD2—schizophrenia	8.18e-05	0.0125	CrCbGaD
Maprotiline—Desipramine—HTR2C—schizophrenia	8.17e-05	0.0125	CrCbGaD
Maprotiline—Desipramine—HTR1A—schizophrenia	7.93e-05	0.0121	CrCbGaD
Maprotiline—Imipramine—SLC6A3—schizophrenia	7.68e-05	0.0117	CrCbGaD
Maprotiline—Nortriptyline—CYP1A2—schizophrenia	7.49e-05	0.0114	CrCbGaD
Maprotiline—Atomoxetine—HTR2A—schizophrenia	7.24e-05	0.0111	CrCbGaD
Maprotiline—Imipramine—HTR2C—schizophrenia	6.93e-05	0.0106	CrCbGaD
Maprotiline—Desipramine—SLC6A4—schizophrenia	6.77e-05	0.0103	CrCbGaD
Maprotiline—Desipramine—DRD2—schizophrenia	6.74e-05	0.0103	CrCbGaD
Maprotiline—Imipramine—HTR1A—schizophrenia	6.73e-05	0.0103	CrCbGaD
Maprotiline—Atomoxetine—CYP2D6—schizophrenia	6.62e-05	0.0101	CrCbGaD
Maprotiline—Nortriptyline—HTR2A—schizophrenia	6.32e-05	0.00966	CrCbGaD
Maprotiline—Desipramine—CYP1A2—schizophrenia	6.17e-05	0.00942	CrCbGaD
Maprotiline—Nortriptyline—CYP2D6—schizophrenia	5.78e-05	0.00883	CrCbGaD
Maprotiline—Imipramine—SLC6A4—schizophrenia	5.74e-05	0.00878	CrCbGaD
Maprotiline—Imipramine—DRD2—schizophrenia	5.71e-05	0.00873	CrCbGaD
Maprotiline—Imipramine—CYP1A2—schizophrenia	5.23e-05	0.00799	CrCbGaD
Maprotiline—Desipramine—HTR2A—schizophrenia	5.2e-05	0.00795	CrCbGaD
Maprotiline—Desipramine—CYP2D6—schizophrenia	4.76e-05	0.00727	CrCbGaD
Maprotiline—Imipramine—HTR2A—schizophrenia	4.41e-05	0.00674	CrCbGaD
Maprotiline—Imipramine—CYP2D6—schizophrenia	4.04e-05	0.00617	CrCbGaD
Maprotiline—Desipramine—ABCB1—schizophrenia	3.4e-05	0.00519	CrCbGaD
Maprotiline—Imipramine—ABCB1—schizophrenia	2.88e-05	0.0044	CrCbGaD
Maprotiline—CHRM3—Signaling Pathways—DRD4—schizophrenia	5.7e-06	4.03e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PRKD1—schizophrenia	5.7e-06	4.03e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—DPYD—schizophrenia	5.66e-06	4e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD4—schizophrenia	5.64e-06	3.99e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—YWHAZ—schizophrenia	5.63e-06	3.98e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GAPDH—schizophrenia	5.61e-06	3.97e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CNR1—schizophrenia	5.58e-06	3.95e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CLOCK—schizophrenia	5.56e-06	3.94e-05	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	5.54e-06	3.92e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—schizophrenia	5.53e-06	3.91e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB3—schizophrenia	5.5e-06	3.89e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—COMT—schizophrenia	5.49e-06	3.89e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CNR1—schizophrenia	5.49e-06	3.88e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CNR1—schizophrenia	5.48e-06	3.87e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTP1—schizophrenia	5.47e-06	3.87e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CNR1—schizophrenia	5.46e-06	3.86e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MAOA—schizophrenia	5.45e-06	3.86e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOE—schizophrenia	5.44e-06	3.85e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR7—schizophrenia	5.44e-06	3.85e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CNR1—schizophrenia	5.44e-06	3.85e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—S100B—schizophrenia	5.43e-06	3.84e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CACNB2—schizophrenia	5.42e-06	3.84e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TPH2—schizophrenia	5.42e-06	3.84e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CNR1—schizophrenia	5.39e-06	3.81e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOA1—schizophrenia	5.38e-06	3.81e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD2—schizophrenia	5.35e-06	3.79e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HTR7—schizophrenia	5.35e-06	3.79e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD2—schizophrenia	5.34e-06	3.78e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR7—schizophrenia	5.34e-06	3.78e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—DPYD—schizophrenia	5.33e-06	3.77e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR7—schizophrenia	5.32e-06	3.77e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD2—schizophrenia	5.32e-06	3.77e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD2—schizophrenia	5.31e-06	3.76e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR7—schizophrenia	5.31e-06	3.76e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—schizophrenia	5.3e-06	3.75e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CACNA1C—schizophrenia	5.26e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR7—schizophrenia	5.26e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD2—schizophrenia	5.26e-06	3.72e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ESR1—schizophrenia	5.2e-06	3.68e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB4—schizophrenia	5.19e-06	3.67e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ABCB1—schizophrenia	5.17e-06	3.66e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOE—schizophrenia	5.14e-06	3.64e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PRL—schizophrenia	5.14e-06	3.64e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3C2A—schizophrenia	5.13e-06	3.63e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOA1—schizophrenia	5.08e-06	3.6e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PRL—schizophrenia	5.06e-06	3.58e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PRL—schizophrenia	5.04e-06	3.57e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PRL—schizophrenia	5.03e-06	3.56e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PLA2G4A—schizophrenia	5.02e-06	3.55e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTM1—schizophrenia	5.02e-06	3.55e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PRL—schizophrenia	5.01e-06	3.55e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PRL—schizophrenia	4.96e-06	3.51e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CACNA1C—schizophrenia	4.96e-06	3.51e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOE—schizophrenia	4.92e-06	3.48e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ESR1—schizophrenia	4.91e-06	3.47e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	4.88e-06	3.45e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOA1—schizophrenia	4.87e-06	3.44e-05	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.86e-06	3.44e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3C2A—schizophrenia	4.83e-06	3.42e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NRG1—schizophrenia	4.79e-06	3.39e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—S100B—schizophrenia	4.79e-06	3.39e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GAPDH—schizophrenia	4.75e-06	3.36e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MEF2C—schizophrenia	4.75e-06	3.36e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GSK3B—schizophrenia	4.72e-06	3.34e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CLOCK—schizophrenia	4.71e-06	3.33e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—S100B—schizophrenia	4.71e-06	3.33e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—S100B—schizophrenia	4.7e-06	3.33e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ESR1—schizophrenia	4.7e-06	3.33e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.7e-06	3.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—S100B—schizophrenia	4.69e-06	3.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—S100B—schizophrenia	4.67e-06	3.31e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	4.65e-06	3.29e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—S100B—schizophrenia	4.63e-06	3.27e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP2D6—schizophrenia	4.6e-06	3.25e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SNAP25—schizophrenia	4.6e-06	3.25e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TPH2—schizophrenia	4.59e-06	3.25e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CACNB2—schizophrenia	4.59e-06	3.25e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	4.59e-06	3.25e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB4—schizophrenia	4.58e-06	3.24e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—DPYD—schizophrenia	4.52e-06	3.2e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB4—schizophrenia	4.51e-06	3.19e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB4—schizophrenia	4.5e-06	3.18e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB3—schizophrenia	4.49e-06	3.17e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB4—schizophrenia	4.48e-06	3.17e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB4—schizophrenia	4.47e-06	3.16e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GSK3B—schizophrenia	4.45e-06	3.15e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MTHFR—schizophrenia	4.44e-06	3.14e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB4—schizophrenia	4.42e-06	3.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SNAP25—schizophrenia	4.33e-06	3.07e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—schizophrenia	4.32e-06	3.06e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	4.31e-06	3.05e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GSK3B—schizophrenia	4.26e-06	3.02e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	4.24e-06	3e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	4.23e-06	2.99e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NRG1—schizophrenia	4.23e-06	2.99e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	4.21e-06	2.98e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PLA2G4A—schizophrenia	4.2e-06	2.97e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CACNA1C—schizophrenia	4.2e-06	2.97e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MEF2C—schizophrenia	4.19e-06	2.96e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PLA2G4A—schizophrenia	4.16e-06	2.94e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP1A2—schizophrenia	4.16e-06	2.94e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NRG1—schizophrenia	4.16e-06	2.94e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NRG1—schizophrenia	4.15e-06	2.94e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NRG1—schizophrenia	4.14e-06	2.93e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—schizophrenia	4.13e-06	2.92e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NRG1—schizophrenia	4.12e-06	2.92e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MEF2C—schizophrenia	4.12e-06	2.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MEF2C—schizophrenia	4.11e-06	2.91e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MEF2C—schizophrenia	4.1e-06	2.9e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TH—schizophrenia	4.1e-06	2.9e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3C2A—schizophrenia	4.09e-06	2.9e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MEF2C—schizophrenia	4.09e-06	2.89e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOA1—schizophrenia	4.09e-06	2.89e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NRG1—schizophrenia	4.08e-06	2.89e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—YWHAZ—schizophrenia	4.05e-06	2.86e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MEF2C—schizophrenia	4.05e-06	2.86e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—schizophrenia	4.01e-06	2.84e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	3.98e-06	2.82e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—YWHAZ—schizophrenia	3.97e-06	2.81e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOA1—schizophrenia	3.97e-06	2.81e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	3.96e-06	2.8e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB3—schizophrenia	3.96e-06	2.8e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—YWHAZ—schizophrenia	3.95e-06	2.79e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP1A2—schizophrenia	3.92e-06	2.77e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—YWHAZ—schizophrenia	3.91e-06	2.77e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB3—schizophrenia	3.9e-06	2.76e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB3—schizophrenia	3.89e-06	2.75e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB3—schizophrenia	3.87e-06	2.74e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB3—schizophrenia	3.86e-06	2.73e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TH—schizophrenia	3.86e-06	2.73e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ESR1—schizophrenia	3.83e-06	2.71e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB3—schizophrenia	3.83e-06	2.71e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—schizophrenia	3.81e-06	2.7e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—schizophrenia	3.74e-06	2.65e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—schizophrenia	3.73e-06	2.64e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—schizophrenia	3.72e-06	2.63e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—schizophrenia	3.68e-06	2.6e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2D6—schizophrenia	3.67e-06	2.6e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SNAP25—schizophrenia	3.67e-06	2.6e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—schizophrenia	3.54e-06	2.51e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOA1—schizophrenia	3.5e-06	2.48e-05	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—schizophrenia	3.5e-06	2.47e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—schizophrenia	3.49e-06	2.47e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—COMT—schizophrenia	3.49e-06	2.47e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—schizophrenia	3.48e-06	2.46e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GSK3B—schizophrenia	3.48e-06	2.46e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTP1—schizophrenia	3.47e-06	2.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—schizophrenia	3.47e-06	2.45e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MAOA—schizophrenia	3.46e-06	2.45e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—schizophrenia	3.46e-06	2.45e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOA1—schizophrenia	3.45e-06	2.44e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOA1—schizophrenia	3.44e-06	2.43e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOA1—schizophrenia	3.43e-06	2.43e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—schizophrenia	3.42e-06	2.42e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOA1—schizophrenia	3.42e-06	2.42e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOA1—schizophrenia	3.38e-06	2.39e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ESR1—schizophrenia	3.38e-06	2.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ESR1—schizophrenia	3.33e-06	2.35e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ESR1—schizophrenia	3.32e-06	2.35e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ESR1—schizophrenia	3.31e-06	2.34e-05	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—schizophrenia	3.3e-06	2.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ESR1—schizophrenia	3.3e-06	2.33e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—COMT—schizophrenia	3.28e-06	2.32e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TH—schizophrenia	3.27e-06	2.32e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTP1—schizophrenia	3.27e-06	2.31e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ESR1—schizophrenia	3.27e-06	2.31e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MAOA—schizophrenia	3.26e-06	2.31e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.19e-06	2.26e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTM1—schizophrenia	3.19e-06	2.26e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—schizophrenia	3.17e-06	2.25e-05	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—schizophrenia	3.16e-06	2.24e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EP300—schizophrenia	3.1e-06	2.2e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCB1—schizophrenia	3.09e-06	2.19e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GSK3B—schizophrenia	3.07e-06	2.17e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GSK3B—schizophrenia	3.02e-06	2.14e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GSK3B—schizophrenia	3.01e-06	2.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—schizophrenia	3e-06	2.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3e-06	2.13e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GSK3B—schizophrenia	3e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—schizophrenia	3e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GSK3B—schizophrenia	2.99e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GSK3B—schizophrenia	2.96e-06	2.1e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EP300—schizophrenia	2.93e-06	2.07e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—schizophrenia	2.87e-06	2.03e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—schizophrenia	2.82e-06	1.99e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EP300—schizophrenia	2.81e-06	1.99e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COMT—schizophrenia	2.78e-06	1.97e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—schizophrenia	2.77e-06	1.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MAOA—schizophrenia	2.76e-06	1.95e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.68e-06	1.9e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—schizophrenia	2.65e-06	1.88e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—schizophrenia	2.62e-06	1.86e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCB1—schizophrenia	2.62e-06	1.85e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOA1—schizophrenia	2.59e-06	1.83e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	2.58e-06	1.82e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLA2G4A—schizophrenia	2.54e-06	1.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—schizophrenia	2.54e-06	1.8e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—schizophrenia	2.47e-06	1.75e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOA1—schizophrenia	2.44e-06	1.73e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—EP300—schizophrenia	2.36e-06	1.67e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—schizophrenia	2.34e-06	1.66e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EP300—schizophrenia	2.29e-06	1.62e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—schizophrenia	2.27e-06	1.61e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—schizophrenia	2.25e-06	1.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	2.24e-06	1.58e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—schizophrenia	2.23e-06	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	2.23e-06	1.57e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—schizophrenia	2.22e-06	1.57e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—schizophrenia	2.22e-06	1.57e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—schizophrenia	2.2e-06	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—schizophrenia	2.1e-06	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—schizophrenia	2.09e-06	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOA1—schizophrenia	2.07e-06	1.46e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—schizophrenia	2.07e-06	1.46e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—schizophrenia	2.03e-06	1.44e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—schizophrenia	2.03e-06	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—schizophrenia	2.02e-06	1.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EP300—schizophrenia	2.02e-06	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—schizophrenia	2.01e-06	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—schizophrenia	2.01e-06	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—schizophrenia	2e-06	1.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EP300—schizophrenia	1.99e-06	1.41e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EP300—schizophrenia	1.98e-06	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EP300—schizophrenia	1.98e-06	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EP300—schizophrenia	1.97e-06	1.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EP300—schizophrenia	1.95e-06	1.38e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—schizophrenia	1.88e-06	1.33e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—schizophrenia	1.77e-06	1.25e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—schizophrenia	1.7e-06	1.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—schizophrenia	1.64e-06	1.16e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—EP300—schizophrenia	1.49e-06	1.06e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—schizophrenia	1.44e-06	1.02e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—schizophrenia	1.42e-06	1.01e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—schizophrenia	1.42e-06	1.01e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—schizophrenia	1.42e-06	1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—schizophrenia	1.41e-06	1e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—schizophrenia	1.41e-06	9.97e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—EP300—schizophrenia	1.41e-06	9.97e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—schizophrenia	1.4e-06	9.88e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—schizophrenia	1.38e-06	9.78e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—schizophrenia	1.22e-06	8.63e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—schizophrenia	1.2e-06	8.49e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—schizophrenia	1.2e-06	8.48e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—schizophrenia	1.19e-06	8.45e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—EP300—schizophrenia	1.19e-06	8.44e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—schizophrenia	1.19e-06	8.42e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—schizophrenia	1.18e-06	8.34e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—schizophrenia	9.03e-07	6.39e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—schizophrenia	8.51e-07	6.02e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—schizophrenia	7.21e-07	5.1e-06	CbGpPWpGaD
